期刊文献+

腹膜保护——透析液以外的影响因素 被引量:1

Protecting the peritoneal membrane: factors beyond peritoneal dialysis solutions
下载PDF
导出
摘要 腹膜透析(PD)是终末期肾病的主要肾脏替代疗法之一。尽管新型透析液具有良好的生物相容性,但其腹膜的保护作用尚未被临床证实,究其原因在于PD患者存在除PD液以外,同样能影响腹膜结构的其他因素。本文主要综述除PD液影响腹膜结构和功能危险因素,为腹膜保护找到新的方法。 Peritoneal dialysis (PD) is one of the main renal replacement therapy for end-stage renal disease.Although newer solutions have excellent biocompatibility,their clinical benefit on the preservation of peritoneal membrane integrity remains unproven so far.The difficulties in showing a benefit of the newer,more biocompatible solutions in the clinical setting can be explained by the fact that other factors also affect the properties of the peritoneal membrane.This review focuses on factors that potentially influence the integrity of the peritoneal membrane,other than those associated with the peritoneal dialysis fluid itself.And attention should be paid to them in order to find new approaches to protect the peritoneal membrane.
出处 《肾脏病与透析肾移植杂志》 CAS CSCD 北大核心 2013年第4期380-384,共5页 Chinese Journal of Nephrology,Dialysis & Transplantation
基金 国家自然科学基金(81070562) 江苏省医学重点人才项目(RC2011124)
关键词 腹膜透析 腹膜衰竭 危险因素 peritoneal dialysis peritoneal failure risk factors
  • 相关文献

参考文献30

  • 1马坤岭,张晓良.中性pH值、低葡萄糖降解产物腹膜透析液的生物相容性[J].肾脏病与透析肾移植杂志,2011,20(6):571-575. 被引量:4
  • 2Srivastava S,Hildebrand S,Fan SL,et al.Long-term follow-up of patients randomized to biocompatible or conventional peritoneal dialysis solutions show no difference in peritonitis or technique survival.Kidney Int,2011,80(9):986-991.
  • 3Van BiesenW,Van der Tol A,Veys N,et al.The personal dialysis capacity test is superior to the peritoneal equilibration test to discriminate inflammation as the cause of fast transport status in peritoneal dialysis patients.Clin J Am Soc Nephrol,2006,1 (2):269-274.
  • 4Mizumasa T,Hirakata H,Kuroki Y,et al.Diabetes influences peritoneal morphology in uremic patients at the initiation of peritoneal dialysis.Perit Dial Int,2013,33 (2):175-181.
  • 5Honda K,Hamada C,Nakayama M,et al.Impact of uremia,diabetes,and peritoneal dialysis itself on the pathogenesis of peritoneal sclerosis:a quantitative study of peritoneal membrane morphology.Clin J Am Soc Nephrol,2008,3(3):720-728.
  • 6Stoenoiu MS,De Vriese AS,Brouet A,et al.Experimental diabetes induces functional and structural changes in the peritoneum.Kidney Int,2002,62 (2):668-678.
  • 7García-López E,Lindholm B,Davies S.An update on peritoneal dialysis solutions.Nat Rev Nephrol,2012,8 (4):224-233.
  • 8Wang HY,Lin CY,Chien CC.et al.Impact of uremic environment on peritoneum:a proteomic view.J Proteomics,2012,75 (7):2053-2063.
  • 9Osada S,Hamada C,Shimaoka T,et al.Alterations in proteoglycan components and histopathology of the peritoneum in uraemic and peritoneal dialysis (PD) patients.Nephrol Dial Transplant,2009,24(11):3504-3512.
  • 10De Vriese AS,Tilton RG,Mortier S,et al.Myofibroblast transdifferentiation of mesothelial cells is mediated by RAGE and contributes to peritoneal fibrosis in uraemia.Nephrol Dial Transplant,2006,21 (9):2549-2555.

二级参考文献62

  • 1Williams JD, Craig K J, Topley N, et al. Morphologic changes in the peritoneal membrane of patients with renal disease. J Am Soc Nephrol,2002,13 ( 2 ) :470 - 479.
  • 2Williams JD, Craig K J, Topley N, et al. Peritoneal dialysis : changes to the structure of the peritoneal membrane and potential for biocompatible solutions. Kidney Int ,2003,84 (Suppl) :S158 -161.
  • 3Contreras-Velazquez JC, Soto V, Jaramillo-Rodriguez Y, et al. Clinical outcomes and peritoneal histology in patients starting peritoneal dialysis are related to diabetic status and serum albumin levels. Kidney Int,2008,108 (Suppl) : S34 - 41.
  • 4Rubin J, Herrera GA, Collins D. An autopsy study of the peritoneal cavity from patients on continuous ambulatory peritoneal dialysis. Am J Kidney Dis,1991,18( 1 ) :97 - 102.
  • 5Kawaguchi Y, Hasegawa T, Nakayama M, et al. Issues affecting the longevity of the continuous peritoneal dialysis therapy. Kidney Int, 1997,62 (Suppl) : S105 - 107.
  • 6Nessim SJ, Perl J, Bargman JM. The renin-angiotensiu-aldosterone system in peritoneal dialysis:is what is good for the kidney also good for the peritoneum? Kidney Int,2010,78 (1) :23 -28.
  • 7Davies SJ. Longitudinal relationship between solute transport and uhrafiltration capacity in peritoneal dialysis patients. Kidney Int, 2004,66 (6) :2437 - 2445.
  • 8Gilbert RE,Wu LL, Kelly DJ, et al. Pathological expression of renin and angiotensin II in the renal tubule after subtotal nephrectomy. Implications for the pathogenesis of tubulointerstitial fibrosis. Am J Pathol, 1999,155 (2) :429 - 440.
  • 9Noh H, Ha H, Yu MR, et al. Angiotensin II mediates high glucose- induced TGF-betal and fibronectin upregulation in HPMC through reactive oxygen species. Petit Dial Int,2005,25( 1 ) :38 -47.
  • 10Chitalia VC ,Almeida AF,Rai H,et al. Is peritoneal dialysis adequate for hypercatabolic acute renal failure in developing countries? Kidney Int,2002,61 (2) :747 -757.

共引文献5

同被引文献9

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部